Michael J. Dapp, Ph.D.

2012 Pharmacology University of Minnesota, Twin Cities, Minneapolis, MN 
Microbiology Biology, Pharmacology, Virology Biology
"Michael Dapp"
Mean distance: (not calculated yet)


Sign in to add mentor
Louis Mansky grad student 2012 UMN
 (Studies on the basis of HIV-1 variation and its purposeful increase.)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Dapp MJ, Bonnac L, Patterson SE, et al. (2014) Discovery of novel ribonucleoside analogs with activity against human immunodeficiency virus type 1. Journal of Virology. 88: 354-63
Rawson JM, Heineman RH, Beach LB, et al. (2013) 5,6-Dihydro-5-aza-2'-deoxycytidine potentiates the anti-HIV-1 activity of ribonucleotide reductase inhibitors. Bioorganic & Medicinal Chemistry. 21: 7222-8
Dapp MJ, Patterson SE, Mansky LM. (2013) Back to the future: revisiting HIV-1 lethal mutagenesis. Trends in Microbiology. 21: 56-62
Dapp MJ, Heineman RH, Mansky LM. (2013) Interrelationship between HIV-1 fitness and mutation rate. Journal of Molecular Biology. 425: 41-53
Dapp MJ, Holtz CM, Mansky LM. (2012) Concomitant lethal mutagenesis of human immunodeficiency virus type 1. Journal of Molecular Biology. 419: 158-70
Dapp MJ, Clouser CL, Patterson S, et al. (2009) 5-Azacytidine can induce lethal mutagenesis in human immunodeficiency virus type 1. Journal of Virology. 83: 11950-8
See more...